Talphera, Inc.
TLPH Nasdaq· Pharmaceutical Preparations
Last close · Oct 26, 2026
$1.07
KIRA · Stoqly’s AI analyst, in plain words
- Talphera, Inc. had $0.0M of revenue in fiscal 2025. Over five years, revenue changed −65.1% a year on average.
- Its operating margin was −48,157.1%: of every 100 in sales, about −48,157 is left after running the business.
- Talphera, Inc. lost $14.3M in fiscal 2025.
Market cap
—
P/E
—
Revenue
$0.0M
Net income
−$14.3M
Free cash flow
—
Operating margin
−48,157.1%
Talphera, Inc. in 30 seconds · fiscal 2025
Does it make a profit?
−51,035.7%
No. It lost money last year.
What Talphera, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 23, 2026
- Legal name
- TALPHERA, INC.
- CIK
- 0001427925
Talphera, Inc. · TLPH
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $2.8M | $0.0M | $0.7M | $0.0M | $0.0M |
| Revenue growth | −48.0% | −100.0% | — | −100.0% | — |
| Gross margin | −33.2% | — | — | — | — |
| Operating margin | −1,276.3% | — | −2,594.3% | — | −48,157.1% |
| Net income | −$35.1M | $47.8M | −$18.4M | −$13.0M | −$14.3M |
| Net margin | −1,245.5% | — | −2,826.0% | — | −51,035.7% |
| Diluted EPS | −$5.86 | $5.72 | −$1.29 | — | — |
| Cash | |||||
| Cash from operations | −$30.0M | −$28.3M | −$17.5M | −$12.7M | −$11.4M |
| Capital expenditure | $1.8M | $0.4M | $0.1M | $0.0M | — |
| Free cash flow | −$31.8M | −$28.7M | −$17.6M | −$12.7M | — |
| FCF margin | −1,129.5% | — | −2,702.3% | — | — |
| Share count change | −93.0% | 23.6% | 92.6% | — | — |
| Debt and strength | |||||
| Cash and short-term investments | $46.6M | $15.8M | $9.4M | $8.9M | $20.4M |
| Debt incl. finance leases | $13.8M | $5.8M | $0.0M | — | — |
| Shareholders' equity | −$35.9M | $21.8M | $14.1M | $8.0M | $17.0M |
| Current ratio | 2.7x | 1.8x | 2.6x | 3.6x | 5.5x |
| Interest coverage | −15.7x | −22.7x | −126.0x | — | — |
| Returns and quality | |||||
| Return on capital | — | −214.2% | −282.4% | — | — |
| Return on equity | — | — | −102.4% | −117.7% | −114.2% |
| Return on tangible equity | — | 325.7% | −348.0% | — | −173.9% |
| Piotroski F-score | 5 | 3 | 4 | — | — |
| Altman Z'' | −20.6 | −30.4 | −71.9 | −84.1 | −49.6 |
Insiders bought, 12 months
$0.3M
4 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Talphera, Inc. · TLPH
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.07 a share, the company is worth —.
Source: SEC EDGAR XBRL filings (CIK 0001427925). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.